3ahealth (https://3ahealth.com/) is a Cypriot SME, specializing in the design and development of digital health systems and services. Its mission is to assist healthcare professionals and hospitals in optimizing clinical workflows for the benefit of citizens. Backed by a strong R&D portfolio, 3ahealth transforms research outcomes into commercial products by integrating 3rd party systems and AI models into its solutions. Over the years, 3ahealth participated in numerous national and European projects, where its contribution focuses on developing integrated digital health platforms that bring together AI tools, including medical imaging and point-of-care technologies, as well as 3rd party systems, for collecting, processing, and visualizing data in ways that support clinical decision making. 3ahealth’s flagship product, Alasia Health, (https://alasia.health/) is a cloud-based, interoperable, Software-as-a-Service (SaaS) Electronic Health Record (EHR), designed for use across diverse healthcare settings, from elderly care and rehabilitation centers to clinics and hospitals. Alasia Health is a modular, plug-and-play platform that evolves through continuous R&D&I, offering features that address the real needs of both healthcare professionals and patients. Alasia Health is built based on international interoperability standards and requirements (EHDS regulation), such as the International Patient Summary (IPS) and ePrescription, implemented based on European projects outcomes for cross-border healthcare provision and certified by the IHE (Integrating Healthcare Enterprise) through the IHE- Connectathons. Alasia Health is paired with AlasiaGo, a healthcare professional app for optimizing hospital clinical tasks, such as medication dispensation, food intake, vital signs acquisition, and many more. At the same time myAlasia app is designed to empower patients to co-manage their own health, have unobstructed access to their data, share their health data, and organize their care plan and hospital visits. The company has been awarded the Silver Label for the X-Share Yellow Button for myAlasia mobile app for secure, cross-border health data exchange. Alasia Health is also fully customizable to function as an electronic Case Report Form (eCRF) system.
3ahealth is interested in collaborating with relevant partners towards creating winning consortia in European calls.
Partner seeks Consortium/Coordinator
Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Alasia Health, is a citizen-centered, interoperable and privacy-preserving EHR solution (alasia.health)
Partner seeks Consortium/Coordinator
Destination 6: HORIZON-HLTH-2027-02-IND-02-two-stage: Portable and versatile Point-of-care diagnostics
Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Destination 2: HORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change
Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Destination 1: HORIZON-HLTH-2027-01-STAYHLTH-01: Addressing disabilities through the life course to support independent living and inclusion
Destination 5: HORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Destination 4: HORIZON-HLTH-2027-01-CARE-02: Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases